Professor Lily Yao

Professor Lily Yao, Professor in Health Economics, specialises in economic evaluations alongside large clinical trials and decision-analytic models, particularly in health technology assessment. She has successfully led on the economic components for more than 30 largescale studies, including commissions from the National Institute of Clinical Excellence (NICE).

Professor Yao’s research interests include economic evaluation in public health. She is currently conducting several research projects in public health including projects to address antibiotic resistance in China, mental health as well as multi-morbidity and public health policies in COVID-19.

Professor Yao is working in collaboration with academics at Beijing Normal University to conduct modelling of population migration, disease spread and the effect of interventions in China. She is also part of a group of public health experts and academics calling for the public to wear face coverings in public places to reduce the spread of the COVID-19 virus.

Media coverage

• Sky news
• Springer Link
• SSRN
• Expert Public Health COVID-19 Forum
• Guardian
• Daily Mail

• Peripheral arterial disease, High blood pressure and Aneurysm Screening Trial (PHAST) – An evaluation of the acceptability, effectiveness and cost effectiveness of screening for peripheral arterial disease and high blood pressure at the same time as abdominal aortic aneurysm. Start Date 01/04/2020  End Date 30/06/2028. total grant over £2m
• PGfAR Competition 29 Stage 2; Reference: NIHR200868 Date submitted:  Programme Programme Grants for Applied Research Call PGfAR Competition 29 Stage 2 Lead Applicant Professor Peter McCulloch Host organisation Oxford University Hospitals NHS Foundation Trust Research. Title: RESPOND study (Rescue for Emergency Surgery Patients Observed to uNdergo acute Deterioration) Start Date 01/03/2020  End Date. Prof Yao is co-applicant and leads health economics of the project. Total grant over £2m
• The UK-China AMR Hub on Strategies to reduce the burden of antibiotic resistance in China.  This project is led by Professors Helen Lambert in Bristol and Bo Zheng at Peking University in Beijing funded by a joint UKRI (UK)-NSFC (China) Newton Fund initiative. Prof Yao is CO-PI leads WP3 and methodological group. UK Hub partners (Bristol, Leicester, Bath, Southampton, Public Health England and North Bristol NHS Trust). Total funding in the UK side: Total grant about  £2m; Funded Period: Feb 19 - Jan 22. Prof Yao is co-applicant and leads health economics of the project.

Sam Tromans, Guiqing Yao, Reza Kiani, Regi Alexander, Mohammed Al-Uzri, Traolach Brugha. An investigation of the prevalence of autism among adults admitted to acute mental health wards: A cross-sectional study.  accepted for publication in BMJ open.

Letouze D, Yao G, Clarke SC. The costs associated with the public health management of a cluster of meningococcal infection in England. Vaccine. 2014 Sep 29;32(43):5549-51. doi: 10.1016/j.vaccine.2014.08.044. Epub 2014 Aug 27. PMID: 25173479

Wu J., Zhu S., Yao G., Mohammed M.A., Marshall T. Patient Factors Influencing the Prescribing of Lipid Lowering Drugs for Primary Prevention in UK General Practice: A National Retrospective Cohort Study. PLOT PLoS One. 2013 Jul 26;8(7):e67611.

Yao G., Novielli N., Manaseki-Holland S., Chen Y., van der Klink M., Lilford R.J.. Pre-development evaluation of service delivery interventions: an application to an intervention to improve clinical handover.  BMJ Qual Saf. 2012 Dec;21 Suppl 1:i29-38

Zhu, Shihua, Song, Fujian, Lilford, Richard, Bayliss, Sue, Chilton, Peter, Cummins, Carole, Duffy, John and Yao, GuiqingLily (2012) Ambu aScope2 in unexpected difficult airways management. External Assessment Report  Birmingham, GB NICE 140pp.  https://www.nice.org.uk/guidance/mtg14/resources/ambu-ascope2-for-use-in-unexpected-difficult-airways-eac-assessment-report2

Yao G., Freemantle N., Marcus F.,Tharmanathan P., Coats A. and Poole-Wilson P.A.. Long-Term Cost-effectiveness Analysis of Nebivolol Compared With Placebo In Elderly Patients With Heart Failure – An Individual Patient based Simulation Model – Pharmacoeconomics. 2008;26(10):879-889.

Yao G., Freemantle N., Calvert M. J., Bryan S., Claude, Daubert. Cleland J.G.F. The Long-term Cost-Effectiveness of Cardiac Resynchronization Therapy with or Without an Implantable Cardioverter-Defibrillator. European Heart Journal 2007 28: 42-51.

Miners A., Yao G., Raftery J, Taylor R.. Calcineurin Inhibitors in Renal Transplantation: A Review of Their Cost Effectiveness. Pharmacoeconomics. 2007;25(11):935-47

Wilson J, Yao GL, Raftery J, Bohlius J, Brunskill S, Sandercock J, Bayliss S, Moss P, Stanworth S, Hyde C. A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment. Health Technol Assess. 2007 Apr;11(13):1-202, iii-iv. Review.

Yao G., Albon E., Adi, Y, Milford D., Bayliss S., Ready A., Raftery J., and Taylor R.. A systematic review and economic model of the clinical and cost-effectiveness of immunosuppressive therapy for renal transplantation in children.. Health Technology Assessment. 2006 Dec;10 (49):1-178.

MRes Health economics.